Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Maspion Indonesia Tbk. (BMAS) vs Merck Tbk. (MERK) Price & Performance

Bank Maspion Indonesia Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Maspion Indonesia Tbk. vs Merck Tbk. — how do they compare? Bank Maspion Indonesia Tbk. trades at Rp492 (market cap 8.78T, 47K 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Bank Maspion Indonesia Tbk. is far larger — about 5× Merck Tbk.'s market cap, and Bank Maspion Indonesia Tbk. is more actively traded (47K versus 29.1K). Which is the better fit depends on your goals.

BMASMERK
Market Cap
8.78T1.75T
Volume
47K29.1K
Lot
470291
Turnover
23.16M113.37M
Average Price
492.743,895.98
Value
23.16M113.37M
Indicative Equilibrium Price
4923,890
Indicative Equilibrium Volume
31

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMAS
View details
MERK
View details

About Bank Maspion Indonesia Tbk.

PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.

Read more on BMAS

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK